# South America Oligonucleotide Pool Market

> South America Oligonucleotide Pool Market Research Report By Type (DNA, RNA), By Application (Research, Diagnostic & Therapeutics, Others), By End User (Commercial Research, Pure Academic Research, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.03%
- **2024:** $ 83.5 Million
- **2025:** $ 90.21 Million
- **2035:** $ 195.2 Million
- **Key Players:** Thermo Fisher Scientific (US), Integrated DNA Technologies (US), Agilent Technologies (US), Eurofins Genomics (DE), Biosearch Technologies (US), LGC Group (GB), GenScript (CN), Bioneer (KR), Synthego (US)

**Report ID:** MRFR/HC/55083-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-america-oligonucleotide-pool-market-56849

---

## Market Summary

## **South America Oligonucleotide Pool Market Overview**

As per MRFR analysis, the South America Oligonucleotide Pool Market Size was estimated at 153 (USD Million) in 2023. The industry is expected to grow from 167 (USD Million) in 2024 to 402 (USD Million) by 2035. The market CAGR is expected to be around 8.314% during the forecast period (2025 - 2035).

**Key South America Oligonucleotide Pool Market Trends Highlighted**

The South America Oligonucleotide Pool Market is currently experiencing notable trends that reflect the region's evolving biotechnology landscape. One of the key market drivers is the growing demand for personalized medicine and advanced therapeutic developments, particularly in countries such as Brazil and Argentina. This rise is largely attributed to increased investment in research and development by both public and private sectors aimed at improving healthcare outcomes.

Additionally, the rise in genetic research initiatives supported by government programs is contributing to market growth, with national health organizations advocating for the use of oligonucleotide pools in improving diagnostics and treatment protocols. The South American market offers a plethora of opportunities, particularly in the development of partnerships between academic institutions and biotechnology companies.

The development of innovative oligonucleotide technologies that are specifically designed to address the health challenges that are prevalent in the region, such as pervasive genetic disorders, can be facilitated by such partnerships. Additionally, the regulatory frameworks in South America are becoming increasingly favorable, which is motivating companies to conduct oligonucleotide research.

In recent years, there has been a discernible trend toward the implementation of synthetic biology, which is revolutionizing the research capabilities of South American nations. This technology enhances the utility of oligonucleotides in molecular diagnostics and therapeutics by facilitating more efficient and targeted applications. The development strategies of market participants are also being influenced by the emphasis on sustainable practices within biotechnology.

This emphasis is driven by consumer demand for ethical and eco-friendly solutions. Innovation and collaboration are the driving forces behind these trends, which indicate a promising future for the South America Oligonucleotide Pool Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

**South America Oligonucleotide Pool Market Drivers**

### **Growing Demand for Personalized Medicine**

The South America Oligonucleotide Pool Market Industry is experiencing significant growth due to the rising interest in personalized medicine, which emphasizes tailored treatments based on individual genetic profiles. The Biotechnology Innovation Organization reported that over 65% of new drug approvals in the last year were linked to personalized medicine approaches. In Argentina and Brazil, government initiatives are supporting the integration of genomics into healthcare to enhance patient outcomes, thereby increasing the demand for oligonucleotide technology.

This growing trend is further supported by partnerships between local research institutions and global companies, which aim to develop innovative therapies for disorders prevalent in the region.

### **Expanding Research and Development Initiatives**

The South America Oligonucleotide Pool Market Industry is notably driven by increased investment in Research and Development (R&D) activities. Various governments across South America are committing additional funding to biotech sectors, evidenced by Brazil's push for bioeconomy investment, allocating over USD 200 million towards biopharmaceutical development. This funding is crucial for advancing oligonucleotide research and applications, particularly in developing treatments for chronic diseases such as diabetes and cardiovascular conditions highly prevalent in South America.

Collaboration between academic institutions and industry leaders is also enhancing the region's R&D capacity, allowing for further growth in the oligonucleotide market.

### **Increase in Genetic Disorders and Chronic Diseases**

The rising incidence of genetic disorders and chronic diseases in South America is a significant driver behind the growth of the South America Oligonucleotide Pool Market Industry. According to the Pan American Health Organization, roughly 25% of the population in South America suffers from at least one chronic disease, such as hypertension or diabetes. The increasing need for effective treatments has led healthcare innovators to explore oligonucleotide therapies actively.

Strong support from local governments in preventative care and treatment of genetic diseases is fostering a conducive environment for growth in this market.

## **South America Oligonucleotide Pool Market Segment Insights**

### **Oligonucleotide Pool Market Type Insights**

The South America Oligonucleotide Pool Market is characterized by its diverse Type segmentation, prominently featuring DNA and RNA, both of which play crucial roles in various biomedical applications. The growing focus on personalized medicine, genetic research, and therapeutic development has significantly bolstered the demand for these oligonucleotides across the region. DNA, being essential for genetic studies and diagnostics, is seeing increased utilization in genomics and clinical trials.

This is driving substantial advancements in Research and Development initiatives. Meanwhile, RNA, which is critical for therapeutic applications, particularly in the burgeoning field of RNA interference and gene therapy, continues to gain traction within biotechnological applications and pharmaceutical innovations. The integration of oligonucleotide technologies in healthcare signifies transformative potentials in combating various diseases.

This thereby enhances the South America Oligonucleotide Pool Market industry overall. The dynamic developments in biotechnology, alongside the expanding pharmaceutical sector, are propelling the growth of these types, aligning with the increasing focus on genomic research and innovative therapeutics. With supportive governmental policies and investments in biotechnological research within South American countries, both DNA and RNA hold significant promise to experience rapid growth.

Their dominance in the oligonucleotide pool segment is expected to continue into the future. As noted, advancements in sequencing technologies and increased funding for scientific research are further facilitating the market growth for both DNA and RNA oligonucleotides, highlighting their integral roles in modern scientific applications. This focus enhances the South America Oligonucleotide Pool Market revenue, driven by both types as they address essential health challenges and contribute to the overall advancement of medical science in the region.

This ongoing evolution points to a vibrant future, where both DNA and RNA continue playing pivotal roles in driving the biotechnological landscape forward, emphasizing their significance within the South America Oligonucleotide Pool Market segmentation.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Oligonucleotide Pool Market Application Insights**

The South America Oligonucleotide Pool Market, particularly within the Application segment, showcases an evolving landscape driven by diverse needs in biotechnology and healthcare. The Research segment plays a crucial role, facilitating advancements in genomics and molecular biology, thus promoting developments in genetic engineering and synthetic biology. Diagnostic applications are significant as they contribute to the accuracy and speed of disease identification.

This is increasingly important for public health systems in South America, especially in the wake of emerging infectious diseases. Therapeutics is another vital area that witnesses rising interest due to the growing demand for precision medicine, where oligonucleotides are used in targeted therapies. Additionally, the 'Others' category reflects emerging applications that are yet to be fully explored, indicating potential growth avenues.

With the supported infrastructure for innovation and research initiatives from various governmental organizations across the region, there are ample opportunities for market growth, although challenges such as regulatory hurdles and high production costs remain. The overall dynamics in this market segment are poised for substantial growth, considering the increasing investment in healthcare and biotechnology in South America.

### **Oligonucleotide Pool Market End User Insights**

The End User segment of the South America Oligonucleotide Pool Market plays a vital role in driving innovation and research across various fields. Within this segment, Commercial Research contributes significantly by enabling advancements in biotechnology, pharmaceuticals, and diagnostics, often requiring tailored oligonucleotide solutions for product development and trials. Pure Academic Research also occupies a prominent place, as universities and research institutions leverage oligonucleotide pools.

These are used for fundamental studies in genetics, molecular biology, and related disciplines, which fosters a collaborative ecosystem promoting scientific inquiry. Additionally, other users encompass a diverse array of small companies, government labs, and clinical research organizations that utilize oligonucleotide pools for varied applications, enhancing the overall flexibility and market reach.

The interplay between these uses not only highlights the importance of the South America Oligonucleotide Pool Market but also underscores the region's progressive stance towards enhancing healthcare and scientific endeavors, making it a crucial component for sustainable growth and innovation in the industry.

### **Oligonucleotide Pool Market Regional Insights**

The South America Oligonucleotide Pool Market is characterized by significant regional dynamics, particularly in Brazil, Mexico, Argentina, and the Rest of South America. Brazil leads the market due to its robust biotechnology and pharmaceutical sectors, along with ongoing investments in Research and Development initiatives, enhancing the demand for oligonucleotide pools. Mexico is emerging as an important player, leveraging its growing life sciences industry and favorable regulatory environment that supports innovation.

Argentina, with a strong academic presence and research institutions, contributes significantly to the overall market through advancements in genomics and biotechnology. The Rest of South America showcases diverse growth opportunities, particularly in countries like Chile and Colombia, where there is a rising investment in health and biotechnology sectors. The trends in these regions indicate a collective push towards personalized medicine, increased public and private funding.

These are for biotech projects, and stronger collaborations between academia and industry, all of which are driving the South America Oligonucleotide Pool Market forward. This regional segmentation reflects a promising landscape for growth, influencing the South America Oligonucleotide Pool Market data and bolstering its future market growth potential.

## **South America Oligonucleotide Pool Market Key Players and Competitive Insights**

The South America [Oligonucleotide Pool Market](../../../reports/oligonucleotide-pool-market-2556) is an emerging sector within the biotechnology industry, influenced by increasing demand for genetic research and diagnostic tools. As advancements in genomic research continue to shape the landscape of healthcare and agriculture, the market is seeing heightened competition among various players. The need for personalized medicine and the development of tailored therapeutic solutions are pushing companies in this market to innovate and optimize their oligonucleotide offerings.

Competitors are focusing on expanding their product portfolios, enhancing their research capabilities, and strengthening their regional presence to capture a larger share of the growing market. Furthermore, strategic collaborations and partnerships are becoming pivotal in overcoming market challenges and facilitating access to a wider range of customer needs across South America.

Agilent Technologies has established a notable presence in the South American Oligonucleotide Pool Market, primarily known for its high-quality product offerings and advanced technologies. The company has leveraged its strong portfolio of oligonucleotide synthesis tools and applications, focusing on providing tailored solutions that meet the specific needs of researchers and developers in the region. Agilent’s strength lies in its robust R&D capabilities, allowing for continuous innovation and the enhancement of its oligonucleotide products.

The company's commitment to customer support and localized services also plays a crucial role in building long-lasting relationships with South American customers. Additionally, Agilent's strategic positioning in the market facilitates easy access for clients seeking reliable oligonucleotide pools for diverse applications such as drug discovery, genomics, and molecular biology.

Biomers is another significant player in the South American Oligonucleotide Pool Market, recognized for its expertise in the synthesis and supply of high-quality oligonucleotides, including custom-designed sequences. The company has carved out a niche by focusing on providing specialized oligonucleotide solutions that cater to both research and diagnostic needs within the region. Biomers boasts an extensive catalog of products and emphasizes its commitment to quality and reliability in each of its offerings.

The firm has also implemented strategic partnerships and potential collaborations to expand its market reach and enhance its service capabilities. In addition, Biomers is well-regarded for its customer-centric approach, ensuring that clients receive comprehensive support throughout their projects. As part of its growth strategy, Biomers seeks to strengthen its position by exploring opportunities for mergers and acquisitions within the biotechnological landscape, further enhancing its competitive edge in the South American market.

### **Key Companies in the South America Oligonucleotide Pool Market Include**

- Agilent Technologies
- [Biomers](https://www.biomers.net/en/products/Catalog_Products.html)
- Egenesis
- TriLink BioTechnologies
- Twist Bioscience
- Integrated DNA Technologies
- Thermo Fisher Scientific
- BioRad Laboratories
- Bioneer
- LGC Group
- Aldevron
- Eurofins Genomics
- GenScript
- Macrogen
- SigmaAldrich

### **South America Oligonucleotide Pool Market Industry Developments**

The South America Oligonucleotide Pool Market is experiencing significant developments, particularly with companies like Agilent Technologies, Thermo Fisher Scientific, and Integrated DNA Technologies expanding their operations in the region. In January 2023, Egenesis reported increased market demand for customized oligonucleotides, driven by advancements in gene editing and molecular diagnostics. TriLink BioTechnologies has also made strides by enhancing its oligonucleotide synthesis capabilities to meet growing demands in the pharmaceutical sector.

Notable mergers and acquisitions have been reported, including Twist Bioscience acquiring a smaller biotech firm in Brazil in March 2023 to bolster its market presence. Additionally, Eurofins Genomics announced a partnership with a regional research institution in June 2023 to develop new applications for oligonucleotides in personalized medicine. Recent growth in the South American pharmaceutical market, with a valuation projected to reach approximately USD 59 billion by 2025.

This is significantly impacting the demand for oligonucleotide products. The overall industry is witnessing a robust expansion as companies such as SigmaAldrich and GenScript continue to invest in Research and Development to innovate and capture a larger market share.

## **Oligonucleotide Pool Market Segmentation Insights**

### **Oligonucleotide Pool Market Type Outlook**

- DNA
- RNA

### **Oligonucleotide Pool Market Application Outlook**

- Research
- Diagnostic & Therapeutics
- Others

### **Oligonucleotide Pool Market End User Outlook**

- Commercial Research
- Pure Academic Research
- Others

### **Oligonucleotide Pool Market Regional Outlook**

- Brazil
- Mexico
- Argentina
- Rest of South America

## Market Drivers

### Expansion of Research Institutions

The oligonucleotide pool market is benefiting from the expansion of research institutions across South America. Countries like Argentina and Chile are investing in state-of-the-art laboratories and research facilities dedicated to genetic research and biotechnology. This expansion is expected to enhance the region's research capabilities, leading to increased innovation in oligonucleotide technologies. For instance, the establishment of new research centers is projected to boost the number of clinical trials involving oligonucleotide therapies, thereby accelerating the development of new products. Furthermore, collaborations between universities and biotech companies are likely to facilitate knowledge transfer and foster a culture of innovation. As a result, the oligonucleotide pool market is anticipated to grow, driven by a robust research ecosystem that supports the development of cutting-edge solutions.

### Growing Awareness of Genetic Testing

In South America, there is a notable increase in awareness regarding the importance of genetic testing, which is positively impacting the oligonucleotide pool market. As individuals become more informed about the benefits of genetic testing for early disease detection and personalized treatment options, the demand for oligonucleotide-based diagnostic tools is likely to rise. Surveys indicate that approximately 60% of the population in urban areas is now aware of genetic testing options, compared to just 30% five years ago. This shift in public perception is expected to drive market growth, as healthcare providers increasingly incorporate genetic testing into routine medical practice. Consequently, the oligonucleotide pool market may experience heightened demand for products that facilitate genetic analysis and personalized medicine.

### Advancements in Delivery Technologies

The oligonucleotide pool market is poised for growth due to advancements in delivery technologies that enhance the efficacy of oligonucleotide therapies. Innovations in nanoparticle-based delivery systems and lipid nanoparticles are enabling more efficient and targeted delivery of oligonucleotides to specific tissues. This is particularly relevant in South America, where the need for effective treatments for various diseases is critical. Recent developments suggest that these delivery technologies can improve the bioavailability and stability of oligonucleotides, potentially increasing their therapeutic effectiveness. As a result, pharmaceutical companies are likely to invest in research and development to optimize these delivery systems, thereby expanding the oligonucleotide pool market. The integration of advanced delivery methods may also facilitate the approval of new therapies, further driving market growth.

### Increasing Investment in Biotechnology

The oligonucleotide pool market in South America is experiencing a surge in investment from both public and private sectors. Governments are recognizing the potential of biotechnology to drive economic growth and improve healthcare outcomes. For instance, Brazil has allocated approximately $200 million to support biotechnology initiatives, which includes funding for research and development in oligonucleotide technologies. This influx of capital is likely to enhance the capabilities of local companies, enabling them to innovate and expand their product offerings. As a result, the oligonucleotide pool market is poised for growth, with increased production capacity and improved access to advanced technologies. Furthermore, collaborations between academic institutions and industry players are expected to foster innovation, thereby contributing to the overall expansion of the market.

### Rising Prevalence of Genetic Disorders

The oligonucleotide pool market in South America is significantly influenced by the increasing prevalence of genetic disorders. Conditions such as cystic fibrosis, muscular dystrophy, and various hereditary cancers are becoming more common, necessitating advanced diagnostic and therapeutic solutions. According to recent studies, approximately 1 in 300 individuals in South America is affected by a genetic disorder, highlighting the urgent need for effective treatments. Oligonucleotide therapies, which target specific genetic mutations, are emerging as promising options. This growing demand for targeted therapies is likely to drive the oligonucleotide pool market, as healthcare providers seek innovative solutions to address these challenges. Consequently, the industry may witness a shift towards personalized medicine, where treatments are tailored to individual genetic profiles.

## Future Outlook

The [Oligonucleotide Pool Market](https://www.marketresearchfuture.com/reports/oligonucleotide-pool-market-2556) is projected to grow at an 8.03% CAGR from 2025 to 2035, driven by advancements in biotechnology, increasing demand for personalized medicine, and rising investments in genetic research.

**New opportunities:**

- Development of customized oligonucleotide synthesis platforms for targeted therapies.
- Expansion of partnerships with biotech firms for innovative product development.
- Implementation of cost-effective high-throughput screening technologies to enhance research efficiency.

By 2035, the oligonucleotide pool market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Application: Gene Synthesis (Largest) vs. Next Generation Sequencing (Fastest-Growing)

In the South America oligonucleotide pool market, the application segment is diverse, with Gene Synthesis holding the largest market share. This method is pivotal in developing tailored oligonucleotides, enabling significant advancements in genetic research and therapeutic developments. Following closely are applications like PCR Amplification and Antisense Oligonucleotides, which also play critical roles but command a smaller proportion of the overall market. Each application addresses unique research needs and leverages distinct technologies to enhance scientific exploration in the region.

Emerging technologies, particularly Next Generation Sequencing, are rapidly changing the landscape, driving growth within the sector. Increasing investment in genetic research, coupled with a booming biotechnology industry in South America, is expected to propel the adoption of advanced applications. Enhanced understanding of genomic data and a burgeoning interest in personalized medicine further accelerate the market growth, enabling these technologies to flourish and meet the evolving needs of researchers and clinicians alike.

Gene Synthesis (Dominant) vs. Antisense Oligonucleotides (Emerging)

Gene Synthesis stands out as the dominant application in the South America oligonucleotide pool market, known for its ability to create custom DNA sequences for various research and industrial applications. This method is extensively used in drug development and gene therapy, resulting in significant investment and innovation in the field. Conversely, Antisense Oligonucleotides are considered an emerging segment, capturing the attention of researchers due to their potential in treating genetic disorders and cancers. While still gaining traction, antisense technologies are being progressively integrated into therapeutic solutions, indicating a growing market presence. The interplay between these two segments illustrates the dynamic landscape of applications wherein Gene Synthesis leads, while Antisense Oligonucleotides represent significant future potential.

### By End Use: Pharmaceutical Companies (Largest) vs. Academic Research (Fastest-Growing)

In the South America oligonucleotide pool market, the distribution of market share among the end-use segments reveals that pharmaceutical companies constitute the largest portion, leveraging their resources for drug development and personalized medicine. In contrast, academic research, driven by increasing governmental and institutional funding, is emerging as the fastest-growing segment, reflecting a surge in innovative research and discovery initiatives across universities and research institutions in the region.

Growth trends in the oligonucleotide pool market are primarily influenced by advancements in biotechnology and increasing demand for personalized therapies. Pharmaceutical companies are investing heavily in oligonucleotide-based therapeutics, while academic research is rapidly expanding due to the need for novel methodologies in gene editing and diagnostics. These trends are creating a competitive environment that fosters collaboration between academic institutions and industry players, propelling the market's growth further.

Pharmaceutical Companies (Dominant) vs. Academic Research (Emerging)

Pharmaceutical companies dominate the South America oligonucleotide pool market, capitalizing on their expertise in drug development and regulatory pathways. Their significant resources permit investment in cutting-edge oligonucleotide therapies, which are crucial for addressing unmet medical needs. Meanwhile, academic research is emerging as a vital player in this landscape, driven by innovations in genomics and molecular biology. The collaboration between academia and industry fosters translational research, ensuring that discoveries in academic settings lead to practical applications in clinical settings. While pharmaceutical companies maintain the dominant market position, the acceleration of academic research indicates a promising shift towards more grassroots innovations, setting the stage for future breakthroughs in therapeutic solutions.

### By Type: Custom Oligonucleotides (Largest) vs. Pre-Designed Oligonucleotides (Fastest-Growing)

In the South America oligonucleotide pool market, Custom Oligonucleotides dominate the landscape, holding the largest share among the various types available. This segment is preferred by researchers and biotech companies due to its tailored applications, allowing for greater specificity in experiments and therapeutic developments. Conversely, Pre-Designed Oligonucleotides are gaining traction, particularly due to their convenience and time efficiency, appealing to various sectors from academia to industry.

Oligonucleotide Types: Custom (Dominant) vs. Pre-Designed (Emerging)

Custom Oligonucleotides are revered for their flexibility and personalized design, catering to specific project needs in the research community. This versatility makes them indispensable in molecular biology applications, particularly in PCR and gene synthesis. On the other hand, Pre-Designed Oligonucleotides have emerged as a practical choice for many researchers who prioritize turnaround time and ease of use. With ready-to-use solutions backed by scientific validation, they offer a compelling choice, particularly among those looking to streamline workflows without sacrificing quality.

### By Technology: Solid Phase Synthesis (Largest) vs. Liquid Phase Synthesis (Fastest-Growing)

In the South America oligonucleotide pool market, the technology segment showcases a competitive landscape with solid phase synthesis holding a significant market share. This traditional method is favored for its efficiency and precision in producing high-quality oligonucleotides. Meanwhile, liquid phase synthesis is emerging rapidly, catering to a growing demand for flexibility and scalability in oligonucleotide production. Microarray technology, though valuable, primarily serves as a supportive tool in gene expression analysis and diagnostics, impacting its overall share in the market.

Technology: Solid Phase Synthesis (Dominant) vs. Liquid Phase Synthesis (Emerging)

Solid phase synthesis remains the dominant technology in the South America oligonucleotide pool market due to its established protocols and ability to deliver high purity oligonucleotides. Its robustness makes it the go-to choice for researchers and developers. Conversely, liquid phase synthesis is gaining traction as an emerging technology, attracting attention for its potential to streamline the oligonucleotide manufacturing process, particularly for large-scale applications. The increasing interest in personalized medicine and genomic research is driving this shift, as liquid phase synthesis can adapt to various oligonucleotide designs more readily, thus offering a competitive edge over traditional methods.

### By Distribution Channel: Online Sales (Largest) vs. Direct Sales (Fastest-Growing)

In the South America oligonucleotide pool market, market share distribution across the distribution channels reveals a significant dominance of online sales. Online sales have become the preferred method for many consumers and institutions alike, capturing a large portion of the market due to the convenience and accessibility they offer. Following this dominant segment, direct sales emerge as a notable contender, providing tailored solutions and services to specific clients that require more personalized attention.
 
The growth trends in the distribution channel segment reflect an increasing shift towards online sales, driven by advancements in technology and the rising preference for e-commerce among researchers and laboratories. Meanwhile, direct sales are experiencing rapid expansion, fueled by the demand for customized solutions and the ability to establish strong relationships with customers. Distributors play a critical role in this market by acting as intermediaries, yet their growth is slower compared to the aforementioned channels as they adapt to changing market dynamics.

Online Sales: Dominant vs. Direct Sales: Emerging

The online sales channel has become the dominant force in the South America oligonucleotide pool market due to its vast reach and ability to meet the needs of a diverse customer base. Facilitating easy access to products and information, online sales cater to both individual researchers and large institutions, providing a level of convenience that is unmatched by traditional methods. On the other hand, direct sales are emerging as a unique segment that offers tailored solutions to specific clients. This approach allows for personal interaction, leading to a deeper understanding of customer requirements. As users increasingly seek customized options, direct sales are positioned to grow rapidly, leveraging strong relationships with clients and providing added value through specialized services.

## Regional Market Share Analysis

### Brazil : Brazil's Dominance in Biotech Sector

Brazil holds a commanding 40.0% share of the South American oligonucleotide pool market, valued at approximately $200 million in 2024. Key growth drivers include increasing investments in biotechnology, a surge in genetic research, and supportive government initiatives aimed at enhancing healthcare. Regulatory frameworks are evolving to facilitate faster approvals for biotech products, while infrastructure improvements in major cities like São Paulo and Rio de Janeiro bolster industrial development.

### Mexico : Mexico's Growth in Biotechnology

With a market share of 15.0%, Mexico's oligonucleotide pool market is valued at around $75 million. The growth is fueled by rising demand for personalized medicine and advancements in genomics. Government initiatives, such as the National Biotechnology Strategy, aim to enhance research capabilities. The market is characterized by increasing collaborations between universities and biotech firms, fostering innovation and consumption patterns that favor local production.

### Argentina : Argentina's Biotech Advancements

Argentina accounts for 12.5% of the South American oligonucleotide pool market, valued at approximately $62.5 million. The growth is driven by a strong focus on agricultural biotechnology and healthcare innovations. Regulatory policies are becoming more favorable, encouraging local production and research. The demand for oligonucleotides is rising in sectors like agriculture and diagnostics, supported by government funding for biotech research.

### Rest of South America : Growth Across South American Markets

The Rest of South America holds a 16.0% market share in the oligonucleotide pool sector, valued at about $80 million. Key growth drivers include increasing healthcare investments and a growing interest in genetic research across countries like Chile and Colombia. Local governments are implementing policies to support biotech innovation. The competitive landscape features both local and international players, with applications spanning diagnostics and therapeutics.

## Competitive Benchmarking

The oligonucleotide pool market in South America is characterized by a dynamic competitive landscape, driven by increasing demand for genetic research and personalized medicine. Key players such as Thermo Fisher Scientific (US), Integrated DNA Technologies (US), and Agilent Technologies (US) are at the forefront, leveraging their extensive portfolios and technological advancements. These companies appear to focus on innovation and strategic partnerships to enhance their market presence. For instance, Thermo Fisher Scientific (US) emphasizes its commitment to expanding its product offerings through continuous research and development, which seems to position it favorably against competitors.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Eurofins Genomics (DE) and GenScript (CN) suggests a trend towards consolidation, as these firms seek to enhance operational efficiencies and broaden their geographic reach.

In October  Integrated DNA Technologies (US) announced the opening of a new facility in Brazil, aimed at increasing its production capacity and improving service delivery in the region. This strategic move is likely to enhance its competitive edge by providing localized support to customers, thereby reducing turnaround times and fostering closer relationships with clients. Such initiatives may also reflect a broader trend of companies investing in regional capabilities to better serve the growing South American market.

In September  Agilent Technologies (US) launched a new line of oligonucleotide synthesis products tailored for high-throughput applications. This innovation is indicative of the company's focus on meeting the evolving needs of researchers and could potentially strengthen its market position by attracting a wider customer base. The introduction of advanced technologies in oligonucleotide synthesis may also signal a shift towards more efficient and cost-effective solutions in the industry.Moreover, in November 2025, Eurofins Genomics (DE) expanded its service offerings by integrating AI-driven analytics into its oligonucleotide design process. This strategic enhancement is likely to improve the precision and efficiency of custom oligonucleotide synthesis, aligning with current trends towards digitalization and automation in the market. Such advancements may not only streamline operations but also provide a competitive advantage in an increasingly technology-driven landscape.

As of November  the competitive trends in the oligonucleotide pool market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancements and supply chain reliability is becoming increasingly evident. Looking ahead, competitive differentiation is expected to evolve, with companies that prioritize innovation and operational excellence likely to emerge as leaders in this rapidly changing market.

## Recent News & Developments

The South America Oligonucleotide Pool Market is experiencing significant developments, particularly with companies like Agilent Technologies, Thermo Fisher Scientific, and Integrated DNA Technologies expanding their operations in the region. In January 2023, Egenesis reported increased market demand for customized oligonucleotides, driven by advancements in gene editing and molecular diagnostics. TriLink BioTechnologies has also made strides by enhancing its oligonucleotide synthesis capabilities to meet growing demands in the pharmaceutical sector.

Notable mergers and acquisitions have been reported, including Twist Bioscience acquiring a smaller biotech firm in Brazil in March 2023 to bolster its market presence. Additionally, Eurofins Genomics announced a partnership with a regional research institution in June 2023 to develop new applications for oligonucleotides in personalized medicine. Recent growth in the South American pharmaceutical market, with a valuation projected to reach approximately USD 59 billion by 2025.

This is significantly impacting the demand for oligonucleotide products. The overall industry is witnessing a robust expansion as companies such as SigmaAldrich and GenScript continue to invest in Research and Development to innovate and capture a larger market share.

## Report Scope

| MARKET SIZE 2024 | 83.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 90.21(USD Million) |
| MARKET SIZE 2035 | 195.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.03% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Thermo Fisher Scientific (US), Integrated DNA Technologies (US), Agilent Technologies (US), Eurofins Genomics (DE), Biosearch Technologies (US), LGC Group (GB), GenScript (CN), Bioneer (KR), Synthego (US) |
| Segments Covered | Type, Application, End-User |
| Key Market Opportunities | Growing demand for personalized medicine drives innovation in the oligonucleotide pool market. |
| Key Market Dynamics | Rising demand for personalized medicine drives growth in the oligonucleotide pool market across South America. |
| Countries Covered | Brazil, Mexico, Argentina, Rest of South America |

## Frequently Asked Questions

**Q: What is the current valuation of the South America oligonucleotide pool market?**
A: As of 2024, the market valuation stands at 167.0 USD Million.

**Q: What is the projected market size for the South America oligonucleotide pool market by 2035?**
A: The market is expected to reach a valuation of 401.53 USD Million by 2035.

**Q: What is the expected CAGR for the South America oligonucleotide pool market during the forecast period?**
A: The market is projected to grow at a CAGR of 8.3% from 2025 to 2035.

**Q: Which application segments are driving the South America oligonucleotide pool market?**
A: Key application segments include Gene Synthesis, PCR Amplification, and Next Generation Sequencing, with valuations ranging from 30.0 to 100.0 USD Million.

**Q: What are the primary end-use sectors for oligonucleotide pools in South America?**
A: The primary end-use sectors include Pharmaceutical Companies and Diagnostic Laboratories, with valuations between 52.0 and 120.0 USD Million.

**Q: What types of oligonucleotides are available in the South America market?**
A: The market offers Custom Oligonucleotides, Pre-Designed Oligonucleotides, and Universal Oligonucleotides, with valuations from 47.0 to 150.0 USD Million.

**Q: What technologies are utilized in the South America oligonucleotide pool market?**
A: Technologies such as Solid Phase Synthesis and Liquid Phase Synthesis are utilized, with valuations ranging from 50.0 to 150.0 USD Million.

**Q: How are oligonucleotide pools distributed in South America?**
A: Distribution channels include Online Sales and Direct Sales, with valuations between 50.0 and 150.0 USD Million.

**Q: Who are the key players in the South America oligonucleotide pool market?**
A: Key players include Thermo Fisher Scientific, Integrated DNA Technologies, and Eurofins Genomics, among others.

**Q: What trends are influencing the growth of the South America oligonucleotide pool market?**
A: Trends such as increased demand for gene editing and advancements in sequencing technologies are likely influencing market growth.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-oligonucleotide-pool-market-56849*